glp-1 and dual glp-1/gip receptor agonists GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica PDB-101: Molecule of the Month:

The potential confounding effect of stem-cell chemokines

[DOI] [PubMed] [Google Scholar] 24.Woo JS, Kim W, Ha SJ, et al

329,330 In degenerative joint diseases like OA, the metabolic balance of chondrocytes is disrupted, leading to the overproduction of degrading enzymes and inflammatory mediators, including iNOS, MMP-13, and ADAMTS5 (a disintegrin and metalloproteinase with thrombospondin motifs 5), which participate in cartilage degradation and inflammatory processes

In addition to generating billions in annual revenue, OZEMPIC and WEGOVYboth of which gained significant attention for their weight loss benefitshave largely avoided the supply shortages that have affected them for years

Glucagon-like peptide-1 cleavage product GLP-1(9-36) amide rescues synaptic plasticity and memory deficits in alzheimers disease model mice